These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 94892)

  • 1. Diagnostic problems in thromboembolism.
    Odegård OR
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):960-6. PubMed ID: 94892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches for the detection of early activation products in thrombotic states.
    Pelzer H; Braun K; Schwarz A; Tourte E; Becker U
    Behring Inst Mitt; 1986 Feb; (79):80-6. PubMed ID: 2941007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism.
    Goldenberg N; Kahn SR; Solymoss S
    J Clin Oncol; 2003 Nov; 21(22):4194-9. PubMed ID: 14615447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis.
    O'Brien JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):116-23. PubMed ID: 4454034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical therapeutic conference: recurrent venous thrombotic and thromboembolic disease.
    Freedman MD
    Am J Ther; 1998 Jan; 5(1):51-6. PubMed ID: 10099038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging anticoagulants: mechanism of action and future potential.
    Klement P; Rak J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial deficiency of antithrombin III].
    Coget JM; Dendien-Bernard S; Dupuis-Cuny C
    Phlebologie; 1987; 40(2):381-91. PubMed ID: 3615614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of hypercoagulability].
    Vinazzer H
    Wien Klin Wochenschr; 1984 Dec; 96(24):872-5. PubMed ID: 6528615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic diseases: biochemical mechanisms and new possibilities of biological diagnosis.
    Amiral J; Fareed J
    Semin Thromb Hemost; 1996; 22 Suppl 1():41-8. PubMed ID: 8807728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacologic aspects of thrombophilia].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):535-49. PubMed ID: 6083924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exploratory strategy in venous thromboembolic disease].
    Elias A; Serradimigni A
    Ann Cardiol Angeiol (Paris); 1989 Oct; 38(8):485-93. PubMed ID: 2688538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple thromboembolism associated with anti-thrombin III deficiency].
    Catarino C; Silva PM; Quininha J; Serra J; da Silva N; Antunes E; Ferreira R; de Oliveira M; Gracias R; Prates A
    Acta Med Port; 1991; 4(3):157-9. PubMed ID: 1950667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thromboembolic disease and congenital venous abnormalities].
    Baskerville PA
    Phlebologie; 1987; 40(2):531-6. PubMed ID: 3039545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism.
    Vikydal R; Korninger C; Kyrle PA; Niessner H; Pabinger I; Thaler E; Lechner K
    Thromb Haemost; 1985 Dec; 54(4):744-5. PubMed ID: 4089808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The possible role of platelet coagulant activities in the pathogenesis of venous thrombosis.
    Walsh PN
    Thromb Diath Haemorrh; 1975 Jun; 33(3):435-43. PubMed ID: 1154305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
    Halbmayer WM; Haushofer A; Toth E
    Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A novel mutation in antithrombin gene results in hereditary antithrombin deficiency].
    Zhang FH; Ding QL; Wu JS; Zhou RF; Wang XF; Xu XC
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):598-601. PubMed ID: 17278425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.